| Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints … S Andrieu, S Guyonnet, N Coley, C Cantet, M Bonnefoy, S Bordes, ... The Lancet Neurology 16 (5), 377-389, 2017 | 768 | 2017 |
| MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data B Vellas, I Carrie, S Gillette-Guyonnet, J Touchon, T Dantoine, ... The journal of prevention of Alzheimer's disease 1 (1), 13, 2014 | 299 | 2014 |
| Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches J Delrieu, PJ Ousset, C Caillaud, B Vellas Journal of Neurochemistry: REVIEW 120, 186-193, 2012 | 185 | 2012 |
| Relationship of regional brain β-amyloid to gait speed N Del Campo, P Payoux, A Djilali, J Delrieu, EO Hoogendijk, Y Rolland, ... Neurology 86 (1), 36-43, 2016 | 147 | 2016 |
| Neuropsychological profile of “cognitive frailty” subjects in MAPT study J Delrieu, S Andrieu, M Pahor, C Cantet, M Cesari, PJ Ousset, T Voisin, ... The journal of prevention of Alzheimer's disease 3 (3), 151, 2016 | 96 | 2016 |
| Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials N Coley, T Ngandu, J Lehtisalo, H Soininen, B Vellas, E Richard, ... Alzheimer's & Dementia 15 (6), 729-741, 2019 | 93 | 2019 |
| Apathy as a feature of prodromal Alzheimer's disease: an FDG‐PET ADNI study J Delrieu, T Desmidt, V Camus, S Sourdet, C Boutoleau‐Bretonnière, ... International journal of geriatric psychiatry 30 (5), 470-477, 2015 | 72 | 2015 |
| Framework Implementation of the INSPIRE ICOPE-CARE program in collaboration with the World Health Organization (WHO) in the Occitania region N Tavassoli, A Piau, C Berbon, J De Kerimel, C Lafont, ... The Journal of frailty & aging 10, 103-109, 2021 | 71 | 2021 |
| Managing cognitive dysfunction through the continuum of Alzheimer’s disease: role of pharmacotherapy J Delrieu, A Piau, C Caillaud, T Voisin, B Vellas CNS drugs 25, 213-226, 2011 | 68 | 2011 |
| RETRACTED: Association between frailty and cognitive impairment: Cross-sectional data from Toulouse Frailty Day Hospital B Fougère, M Daumas, M Lilamand, S Sourdet, J Delrieu, B Vellas, ... Journal of the American Medical Directors Association 18 (11), 990. e1-990. e5, 2017 | 66 | 2017 |
| RETRACTED: Cognitive Frailty: Mechanisms, Tools to Measure, Prevention and Controversy B Fougère, J Delrieu, N Del Campo, G Soriano, S Sourdet, B Vellas Clinics in geriatric medicine 33 (3), 339-355, 2017 | 63 | 2017 |
| Physical activity and cognitive function in middle-aged and older adults: an analysis of 104,909 people from 20 countries P de Souto Barreto, J Delrieu, S Andrieu, B Vellas, Y Rolland Mayo Clinic Proceedings 91 (11), 1515-1524, 2016 | 60 | 2016 |
| Precision prevention of Alzheimer's and other dementias: anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies GB Frisoni, JL Molinuevo, D Altomare, E Carrera, F Barkhof, J Berkhof, ... Alzheimer's & Dementia 16 (10), 1457-1468, 2020 | 58 | 2020 |
| Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study M Ceccaldi, T Jonveaux, A Verger, P Krolak‐Salmon, C Houzard, ... Alzheimer's & Dementia 14 (3), 293-305, 2018 | 57 | 2018 |
| Neuropsychiatric symptoms and risk of progression to Alzheimer’s disease among mild cognitive impairment subjects S Dietlin, M Soto, V Kiyasova, M Pueyo, A de Mauleon, J Delrieu, ... Journal of Alzheimer's Disease 70 (1), 25-34, 2019 | 54 | 2019 |
| Physical Activity and Amyloid‐β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment P de Souto Barreto, S Andrieu, P Payoux, L Demougeot, Y Rolland, ... Journal of the American Geriatrics Society 63 (8), 1634-1639, 2015 | 44 | 2015 |
| Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status J Delrieu, P Payoux, I Carrié, C Cantet, M Weiner, B Vellas, S Andrieu Alzheimer's & dementia 15 (11), 1392-1401, 2019 | 41 | 2019 |
| RETRACTED ARTICLE: Gantenerumab for the treatment of Alzheimer's disease J Delrieu, PJ Ousset, B Vellas Expert opinion on biological therapy 12 (8), 1077-1086, 2012 | 41 | 2012 |
| Blood biomarkers from research use to clinical practice: What must be done? A report from the EU/US CTAD Task Force D Angioni, J Delrieu, O Hansson, H Fillit, P Aisen, J Cummings, JR Sims, ... The journal of prevention of Alzheimer's disease 9 (4), 569-579, 2022 | 39 | 2022 |
| Amyloid beta peptide immunotherapy in Alzheimer disease J Delrieu, PJ Ousset, T Voisin, B Vellas Revue neurologique 170 (12), 739-748, 2014 | 39 | 2014 |
